Related Experiment Video
Updated: Sep 26, 2025

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
Published on: July 8, 2025
Staphylococcus schweitzeri-An Emerging One Health Pathogen?
Chantal Akoua-Koffi1,2, Adèle Kacou N'Douba3,4, Joseph Allico Djaman5
1Centre Hospitalier Universitaire de Bouaké, Bouaké P.O. Box BP 1174, Côte d'Ivoire.
Staphylococcus schweitzeri, found in African wildlife, may pose a zoonotic risk due to potential virulence similar to Staphylococcus aureus. Further research is needed to assess its threat to human and animal health.
Area of Science:
- Microbiology
- Zoonotic Diseases
- One Health
Background:
- The Staphylococcus aureus-related complex includes S. aureus, S. schweitzeri, S. argenteus, S. roterodami, and S. singaporensis.
- S. schweitzeri is primarily found in African wildlife and rarely detected in humans, potentially due to misidentification with S. aureus in routine diagnostics.
- Its animal adaptation characteristics suggest limited human pathogenicity, yet in vitro studies indicate virulence comparable to S. aureus.
Purpose of the Study:
- To review the current scientific understanding of Staphylococcus schweitzeri.
- To identify knowledge gaps regarding its potential impact on human and animal health.
- To evaluate Staphylococcus schweitzeri within the global One Health framework.
Main Methods:
- Literature review of existing research on Staphylococcus schweitzeri.
- Analysis of in vitro assay data concerning virulence factors.
- Assessment of antimicrobial susceptibility and resistance gene data.
Main Results:
- S. schweitzeri is predominantly found in African wildlife and is likely under-reported in humans.
- In vitro studies suggest S. schweitzeri may possess virulence comparable to S. aureus.
- All tested S. schweitzeri isolates were susceptible to antibiotics, with no reported resistance genes like mecA/mecC.
Conclusions:
- Contact with S. schweitzeri-colonized animals may pose a zoonotic infection risk.
- Significant knowledge gaps exist regarding S. schweitzeri's threat to human and animal health.
- Further research is crucial to assess S. schweitzeri's global One Health implications.
More Related Videos
11:00High-throughput Detection of Respiratory Pathogens in Animal Specimens by Nanoscale PCR
Published on: November 28, 2016
07:26Intracranial Subarachnoidal Route of Infection for Investigating Roles of Streptococcus suis Biofilms in Meningitis in a Mouse Infection Model
Published on: July 1, 2018
Related Concept Videos
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
Bacterial Phylum Spirochaetes
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...